Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Association Between the DNA Fragmentation Index (DFI) and the Frequency of Segmental and Total Aneuploidies

NCT06279715 is registered in ClinicalTrials.gov with Clinique Ovo as lead sponsor.

NCT NCT06279715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06279715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Association Between the DNA Fragmentation Index (DFI) and the Frequency of Segmental and Total Aneuploidies
Lead sponsor
Clinique Ovo
Phase
Observational
Overall status
Completed
Start date
January 19, 2024
Completion date
November 14, 2024
Enrollment
537 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

embryo disorder